The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Meningitis B Vaccine Market Research Report 2024
Synopsis
Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.
The global Meningitis B Vaccine market was valued at US$ 23630 million in 2023 and is anticipated to reach US$ 29030 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis B Vaccine.
Report Scope
The Meningitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Novartis
BEXSERO
TRUMENBA
Pfizer
Sanofi Pasteur Inc
Wyeth Pharmaceuticals, Inc.
Segment by Type
MenACWY (Conjugate) Vaccine
MenB (Recombinant Protein) Vaccine
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.
The global Meningitis B Vaccine market was valued at US$ 23630 million in 2023 and is anticipated to reach US$ 29030 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis B Vaccine.
Report Scope
The Meningitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Novartis
BEXSERO
TRUMENBA
Pfizer
Sanofi Pasteur Inc
Wyeth Pharmaceuticals, Inc.
Segment by Type
MenACWY (Conjugate) Vaccine
MenB (Recombinant Protein) Vaccine
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Meningitis B Vaccine Market Overview
1.1 Product Overview and Scope of Meningitis B Vaccine
1.2 Meningitis B Vaccine Segment by Type
1.2.1 Global Meningitis B Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 MenACWY (Conjugate) Vaccine
1.2.3 MenB (Recombinant Protein) Vaccine
1.3 Meningitis B Vaccine Segment by Application
1.3.1 Global Meningitis B Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Meningitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningitis B Vaccine Revenue 2019-2030
1.4.2 Global Meningitis B Vaccine Sales 2019-2030
1.4.3 Global Meningitis B Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meningitis B Vaccine Market Competition by Manufacturers
2.1 Global Meningitis B Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meningitis B Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meningitis B Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Meningitis B Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningitis B Vaccine, Product Type & Application
2.7 Meningitis B Vaccine Market Competitive Situation and Trends
2.7.1 Meningitis B Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meningitis B Vaccine Players Market Share by Revenue
2.7.3 Global Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningitis B Vaccine Retrospective Market Scenario by Region
3.1 Global Meningitis B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meningitis B Vaccine Global Meningitis B Vaccine Sales by Region: 2019-2030
3.2.1 Global Meningitis B Vaccine Sales by Region: 2019-2024
3.2.2 Global Meningitis B Vaccine Sales by Region: 2025-2030
3.3 Global Meningitis B Vaccine Global Meningitis B Vaccine Revenue by Region: 2019-2030
3.3.1 Global Meningitis B Vaccine Revenue by Region: 2019-2024
3.3.2 Global Meningitis B Vaccine Revenue by Region: 2025-2030
3.4 North America Meningitis B Vaccine Market Facts & Figures by Country
3.4.1 North America Meningitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meningitis B Vaccine Sales by Country (2019-2030)
3.4.3 North America Meningitis B Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meningitis B Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meningitis B Vaccine Sales by Country (2019-2030)
3.5.3 Europe Meningitis B Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningitis B Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Meningitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meningitis B Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Meningitis B Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Meningitis B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meningitis B Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Meningitis B Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningitis B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meningitis B Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meningitis B Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningitis B Vaccine Sales by Type (2019-2030)
4.1.1 Global Meningitis B Vaccine Sales by Type (2019-2024)
4.1.2 Global Meningitis B Vaccine Sales by Type (2025-2030)
4.1.3 Global Meningitis B Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Meningitis B Vaccine Revenue by Type (2019-2030)
4.2.1 Global Meningitis B Vaccine Revenue by Type (2019-2024)
4.2.2 Global Meningitis B Vaccine Revenue by Type (2025-2030)
4.2.3 Global Meningitis B Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Meningitis B Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meningitis B Vaccine Sales by Application (2019-2030)
5.1.1 Global Meningitis B Vaccine Sales by Application (2019-2024)
5.1.2 Global Meningitis B Vaccine Sales by Application (2025-2030)
5.1.3 Global Meningitis B Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Meningitis B Vaccine Revenue by Application (2019-2030)
5.2.1 Global Meningitis B Vaccine Revenue by Application (2019-2024)
5.2.2 Global Meningitis B Vaccine Revenue by Application (2025-2030)
5.2.3 Global Meningitis B Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Meningitis B Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Meningitis B Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Meningitis B Vaccine Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 BEXSERO
6.3.1 BEXSERO Corporation Information
6.3.2 BEXSERO Description and Business Overview
6.3.3 BEXSERO Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BEXSERO Meningitis B Vaccine Product Portfolio
6.3.5 BEXSERO Recent Developments/Updates
6.4 TRUMENBA
6.4.1 TRUMENBA Corporation Information
6.4.2 TRUMENBA Description and Business Overview
6.4.3 TRUMENBA Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TRUMENBA Meningitis B Vaccine Product Portfolio
6.4.5 TRUMENBA Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Meningitis B Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Sanofi Pasteur Inc
6.6.1 Sanofi Pasteur Inc Corporation Information
6.6.2 Sanofi Pasteur Inc Description and Business Overview
6.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolio
6.6.5 Sanofi Pasteur Inc Recent Developments/Updates
6.7 Wyeth Pharmaceuticals, Inc.
6.6.1 Wyeth Pharmaceuticals, Inc. Corporation Information
6.6.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolio
6.7.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningitis B Vaccine Industry Chain Analysis
7.2 Meningitis B Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningitis B Vaccine Production Mode & Process
7.4 Meningitis B Vaccine Sales and Marketing
7.4.1 Meningitis B Vaccine Sales Channels
7.4.2 Meningitis B Vaccine Distributors
7.5 Meningitis B Vaccine Customers
8 Meningitis B Vaccine Market Dynamics
8.1 Meningitis B Vaccine Industry Trends
8.2 Meningitis B Vaccine Market Drivers
8.3 Meningitis B Vaccine Market Challenges
8.4 Meningitis B Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Meningitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Meningitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Meningitis B Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Meningitis B Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Meningitis B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Meningitis B Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Meningitis B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Meningitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Meningitis B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningitis B Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningitis B Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Meningitis B Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Meningitis B Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Meningitis B Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Meningitis B Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Meningitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Meningitis B Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Meningitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Meningitis B Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Meningitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Meningitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Meningitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Meningitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Meningitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Meningitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Meningitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Meningitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Meningitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Meningitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Meningitis B Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Meningitis B Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Meningitis B Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Meningitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Meningitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Meningitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Meningitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Meningitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Meningitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Meningitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Meningitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Meningitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Meningitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Meningitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Meningitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Meningitis B Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Meningitis B Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Meningitis B Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Meningitis B Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Meningitis B Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Meningitis B Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Meningitis B Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Meningitis B Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Meningitis B Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Meningitis B Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Meningitis B Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Meningitis B Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Meningitis B Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Meningitis B Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Meningitis B Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Meningitis B Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Meningitis B Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Meningitis B Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Meningitis B Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Meningitis B Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Meningitis B Vaccine Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Meningitis B Vaccine Product
Table 79. Novartis Recent Developments/Updates
Table 80. BEXSERO Corporation Information
Table 81. BEXSERO Description and Business Overview
Table 82. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BEXSERO Meningitis B Vaccine Product
Table 84. BEXSERO Recent Developments/Updates
Table 85. TRUMENBA Corporation Information
Table 86. TRUMENBA Description and Business Overview
Table 87. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. TRUMENBA Meningitis B Vaccine Product
Table 89. TRUMENBA Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Meningitis B Vaccine Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Sanofi Pasteur Inc Corporation Information
Table 96. Sanofi Pasteur Inc Description and Business Overview
Table 97. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Pasteur Inc Meningitis B Vaccine Product
Table 99. Sanofi Pasteur Inc Recent Developments/Updates
Table 100. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 101. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 102. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product
Table 104. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Meningitis B Vaccine Distributors List
Table 108. Meningitis B Vaccine Customers List
Table 109. Meningitis B Vaccine Market Trends
Table 110. Meningitis B Vaccine Market Drivers
Table 111. Meningitis B Vaccine Market Challenges
Table 112. Meningitis B Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meningitis B Vaccine
Figure 2. Global Meningitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Meningitis B Vaccine Market Share by Type in 2023 & 2030
Figure 4. MenACWY (Conjugate) Vaccine Product Picture
Figure 5. MenB (Recombinant Protein) Vaccine Product Picture
Figure 6. Global Meningitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Meningitis B Vaccine Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Meningitis B Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Meningitis B Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Meningitis B Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Meningitis B Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Meningitis B Vaccine Report Years Considered
Figure 15. Meningitis B Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Meningitis B Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Meningitis B Vaccine Players: Market Share by Revenue in 2023
Figure 18. Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Meningitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Meningitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Meningitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Meningitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Meningitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Meningitis B Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Meningitis B Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Meningitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Meningitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Meningitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Meningitis B Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Meningitis B Vaccine by Type (2019-2030)
Figure 54. Global Meningitis B Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Meningitis B Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Meningitis B Vaccine by Application (2019-2030)
Figure 57. Global Meningitis B Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 58. Meningitis B Vaccine Value Chain
Figure 59. Meningitis B Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
